Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer

Background/Aim: Oncotype DX recurrence score (RS) for breast cancer is a useful tool for determining chemotherapy indication but it is expensive and time-consuming. We determined whether four immuno-histochemical markers, namely human epidermal growth factor 2 (HER2), estrogen receptor (ER), progest...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:In Vivo
Hlavní autoři: YAMAMOTO, SHINYA, CHISHIMA, TAKASHI, SHIBATA, YUKAKO, HARADA, FUMI, TAKEUCHI, HIDEKI, YAMADA, AKIMITSU, NARUI, KAZUTAKA, MISUMI, TOSHIHIRO, ISHIKAWA, TAKASHI, ENDO, ITARU
Médium: Artigo
Jazyk:Inglês
Vydáno: International Institute of Anticancer Research 2021
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286534/
https://ncbi.nlm.nih.gov/pubmed/34182528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12522
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky